Malin Corporation | MLC - Capitale Sociale E Riserve





Capitale Sociale E Riserve Cambiamento Data
Akebia Therapeutics USD 27.38M 5.24M 2026-03
Alaunos Therapeutics USD 1.29M 865K 2026-03
ALKERMES USD 1.75B 67.76M 2026-03
Avita Medical AUD -16.65M 3.76M 2025-12
Dianthus Therapeutics USD 1.2B 707.91M 2026-03
Eurofins Scientific SE EUR 3.54B 114.8M 2025-12
Ionis Pharmaceuticals USD 491.41M 2.32M 2026-03
IQVIA Holdings USD 6.22B 282M 2026-03
Lonza CHF 9.13B 513M 2025-12
Malin Corporation EUR 193.2M 75M 2024-12
Moderna USD 7.41B 1.24B 2026-03
Organon & Co USD 903M 151M 2026-03
Ovoca Bio EUR 1.26M 7.41M 2025-06
Revvity USD 7.25B 125.54M 2025-12
Tectonic Therapeutic USD 230.42M 20.91M 2026-03
Viatris USD 14.66B 53.6M 2026-03
Xeris Pharmaceuticals USD 13.01M 678K 2026-03